Documentos para Download:

• PDF Luxação aguda da patela
• PDF Fratura do colo do tálus
• DIR 2022 Saudi Guideline for Low Back Pain
• DIR AAOS/AAHKS The Prevention of Total Hip and Knee Arthroplasty Periprosthetic Joint Infection in Patients Undergoing Dental Procedures
• DIR AAOS/ASSH Management of Distal Radius Fractures Evidence-Based Clinical Practice Guideline
• DIR AAOS Appropriate Use Criteria: Hip Fractures in Older Adults: Acute Treatment
• DIR AAOS Appropriate Use Criteria: Humeral Component Design During Primary Anatomic Total Shoulder Arthroplasty
• DIR AAOS Appropriate Use Criteria: Postoperative Rehabilitation of Low Energy Hip Fractures in Older Adults
• DIR AAOS Appropriate Use Criteria: Prevention of Secondary Hip Fracture and/or Fragility Fracture
• DIR AAOS Appropriate Use Criteria: Treatment for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion
• DIR AAOS Appropriate Use Criteria for Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by Orthopaedic Specialists
• DIR AAOS Appropriate Use Criteria for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery
• DIR AAOS Appropriate Use Criteria for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion
• DIR AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Hip
• DIR AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Knee (Non-Arthroplasty)
• DIR AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures
• DIR AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures with Vascular Injury
• DIR AAOS Appropriate Use Criteria for the Surgical Management of Osteoarthritis of the Knee
• DIR AAOS Appropriate Use Criteria for the Treatment of Distal Radius Fractures (2021)
• DIR AAOS Appropriate Use Criteria for Treatment of Distal Radius Fractures
• DIR AAOS Clinical Practice Guideline for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery
• DIR AAOS Clinical Practice Guideline for the Management of Hip Fractures in Older Adults
• DIR AAOS Clinical Practice Guideline for the Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition)
• DIR AAOS Clinical Practice Guideline on the Management of Osteoarthritis of the Hip
• DIR AAOS Evidence-Based Clinical Practice Guideline for the Surgical Management of Osteoarthritis of the Knee
• DIR AAOS Evidence-Based Clinical Practice Guideline for the Treatment of Clavicle Fractures
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Distal Radius Fracture
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Diaphyseal Femur Fractures
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Supracondylar Humerus Fractures
• DIR AAOS Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline
• DIR Analysis of the scientific evidence on the effectiveness and efficiency of different kinds of hip prosthesis. Recomendations
• DIR Arthroscopy with joint washout in the treatment of knee arthrosis
• DIR Clinical Practice Guideline for Psychological and Other Nonpharmacological Treatment of Chronic Musculoskeletal Pain in Adults
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Opioid Evaluation
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Surgical Risk Assessment
• DIR Diretrizes Brasileiras — Fratura do colo do fêmur no idoso
• DIR Fractures (complex): assessment and management
• DIR Fractures (non-complex): assessment and management
• DIR Fratura do Colo do Fêmur em Idosos (Linha de Cuidado)
• DIR Fratura do Colo do Fêmur em Idosos - Tratamento - Diretrizes Brasileiras
• DIR Guideline for the management of knee and hip osteoarthritis, second edition
• DIR Guideline for the management of knee and hip osteoarthritis. Second edition
• DIR Hastes telescópicas — Correção de deformidades e prevenção de fraturas em crianças e adolescentes em fase de crescimento com osteogênese imperfeita
• DIR Hilano G-F 20 — Intra-articular no tratamento de dor associada com a osteoartrose do joelho
• DIR Hip fracture: management
• DIR Hip fracture in adults
• DIR International Clinical Practice Guideline for the Conservative Management of Chronic Musculoskeletal Neck Pain
• DIR Intra-articular injection of platelet-rich plasma for treating knee arthrosis
• DIR Joint replacement (primary): hip, knee and shoulder
• DIR Joint replacement (primary): hip, knee and shoulder
• DIR Knee and hip osteoarthritis
• DIR KNGF Guideline for Physical Therapy in patients with Low Back Pain
• DIR KNGF Guideline for Physical Therapy in patients with osteoarthritis of the hip and knee
• DIR Korean Medicine Clinical Practice Guideline for Shoulder Pain
• DIR Low back pain and radicular pain: evaluation and management
• DIR Low back pain and sciatica in over 16s
• DIR Low back pain and sciatica in over 16s: assessment and management
• DIR Management of acute deltoid ligament inury in ankle fracture
• DIR Management of Mandibular Condyle Fracture (Second Edition)
• DIR Management of Osteoarthritis (Second Edition)
• DIR MODELS OF LOWER BACK PAIN: RELIABILITY OF A CLASSIFICATION MODEL
• DIR Naproxeno — Osteoartrite de joelho e quadril (ampliação de uso)
• DIR Non-Pharmacological and Pharmacological Management of Acute Pain from Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline from the American College of Physicians and American Academy of Family Physicians
• DIR Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
• DIR Orthotic Management of Adolescent Idiopathic Scoliosis
• DIR Osteoarthritis in over 16s
• DIR Osteoarthritis in over 16s: diagnosis and management
• DIR Pain in the back – Avoiding back pain in children and teenagers Attached the guideline
• DIR Physical Therapist Management of Total Knee Arthroplasty
• DIR Recommandations sur le dépistage pour la prévention primaire des fractures de fragilisation
• DIR Romosozumabe — Mulheres com osteoporose na pós menopausa, a partir de 70 anos, que apresentam risco muito alto de fratura por fragilidade e que falharam (apresentaram duas ou mais fraturas) com o padrão de tratamento medicamentoso.
• DIR Sysadoas. Chondroprotective drugs in the treatment of arthritis
• DIR The health, economic and social impact of low back pain in the Autonomous Community of the Basque Country
• DIR The management of acute/subacute soft tissue injuries to the low back: evidence update and recommendations for clinical practice
• DIR The Management of Low Back Pain in Adults
• DIR The prevention and management of shoulder pain in the hemiplegic patient (Best Practice 7(4))
• DIR Use of radiography in diagnosing low back pain: systematic review
• DIR When to order MRI for low back pain
• DIR WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings
• DIR WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings

Documentos para Download:

• DIR Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies: Guideline From the College of American Pathologists in Collaboration With the American Association for Clinical Chemistry and the American Society for Clinical Pathology
• DIR Laboratory testing for dengue virus
• DIR Laboratory test requests - Part 1
• DIR Laboratory Workup of Amyloidosis
• DIR To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis
• DIR WHO guidelines for plague management

Documentos para Download:

• PDF Síndrome de Prader Willi e tratamento com Somatropina
• DIR AAOS Appropriate Use Criteria for the Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by General Pediatricians and Referring Physicians
• DIR AAOS Appropriate Use Criteria Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age: General Pediatricians and Referring Physicians
• DIR ​Acute diarrhoea in children
• DIR Antisocial behaviour and conduct disorders in children and young people
• DIR Antisocial behaviour and conduct disorders in children and young people: recognition and management
• DIR Asia-Pacific Guidelines for Long-Acting Growth Hormone Therapy
• DIR ASSESSMENT & MANAGEMENT OF ACUTE DIARRHOEA IN CHILDREN
• DIR Babies, children and young people's experience of healthcare
• DIR Bedwetting in children and young people
• DIR Burosumabe — Hipofosfatemia ligada ao cromossomo X em crianças
• DIR Cadeira de rodas para banho em concha infantil — Desenvolvimento e aprimoramento de tecnologias assistivas e meios auxiliares de locomoção
• DIR Carbohydrate intake for adults and children
• DIR Cerebral palsy in children and young people
• DIR Childhood Immunisation
• DIR Child maltreatment: when to suspect maltreatment in under 18s
• DIR Children's attachment
• DIR Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care
• DIR Children’s experiences of postoperative pain management (Best Practice 17(7))
• DIR Claritromicina comprimido — Hanseníase em adultos e crianças com reação adversa ao tratamento de primeira linha
• DIR Claritromicina granulado — Suspensão oral esquema de segunda linha para hanseníase em adultos e crianças com reação adversa ao tratamento de primeira linha
• DIR Clinical Practice Guideline: Tympanostomy Tubes in Children (Update)
• DIR Clinical practice guideline on care in normal childbirth
• DIR Clinical Practice Guideline on major depression in childhood and adolescence. Update.
• DIR Cloridrato de Propranolol (solução oral 3,75 mg/mL) — Hemangiona Infantil
• DIR Constipation in children and young people
• DIR Constipation in children and young people: diagnosis and management
• DIR Dental interventions to prevent caries in children (SIGN CPG 138)
• DIR Developmental follow-up of children and young people born preterm
• DIR Developmental follow-up of children and young people born preterm
• DIR Diagnosis and Management of the Common Cold in Adults and Children
• DIR Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education
• DIR Doses Fixas Pediátricas RHZ (Rifampicina 75 mg + Isoniazida 50 mg + Pirazinamida 150 mg) e RH (Rifampicina 75 mg + Isoniazida 50 mg) comprimidos dispersíveis — Tuberculose em crianças menores de 10 anos
• DIR Early years: promoting health and wellbeing in under 5s
• DIR Effectiveness of non-pharmacological pain management in relieving chronic pain for children and adolescents (Best Practice 14(17))
• DIR End of life care for infants, children and young people
• DIR End of life care for infants, children and young people with life-limiting conditions: planning and management
• DIR ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
• DIR Espectrometria de massas em tandem (MS/MS) — Triagem neonatal em sangue seco, colhido em papelfiltro, para a doença Homocistinúria Clássica (HCU)
• DIR Estradiol adesivo transdérmico — para indução da puberdade em adolescentes do sexo feminino com hipogonadismo hipogonadotrófico orgânico
• DIR Faltering growth: recognition and management of faltering growth in children
• DIR Fever in under 5s
• DIR Fever in under 5s: assessment and initial management
• DIR Guía de Práctica Clínica sobre Cuidados Paliativos en Pediatría
• DIR Guideline: infant feeding in areas of Zika virus transmission
• DIR Guideline for Growth, Health and Developmental Follow-up for Children Born Very Preterm
• DIR Guideline for Growth, Health and Developmental Follow-up for Children Born Very Preterm from School Age to Adulthood
• DIR Guidelines on the management of chronic pain in children
• DIR Harmful sexual behaviour among children and young people
• DIR Hemangioma Infantil
• DIR Identification of risk circumstances of child maltreatment in families
• DIR Implante subdérmico de etonogestrel — Adolescentes de 14 a 17 anos
• DIR Improving early childhood development
• DIR INTEGRATED INTRA AND EXTRA-HOSPITAL APPROACH TO CONDUCT DISORDERS
• DIR Intravenous fluid therapy in children and young people in hospital
• DIR Intravenous fluid therapy in children and young people in hospital
• DIR Jaundice in newborn babies under 28 days
• DIR Jaundice in newborn babies under 28 days
• DIR Looked-after children and young people
• DIR Looked-after children and young people
• DIR Management of Attention Deficit Hyperactive Disorder in Children and Adolescent
• DIR Management of Avulsed Permanent Anterior Teeth in Children (3nd Edition)
• DIR Management of Dengue Fever in Children
• DIR Management of Neonatal Jaundice (Second Edition)
• DIR Management of Rhinosinusitis in Adolescents & Adults
• DIR Management of Severe Early Childhood Caries (2nd Edition)
• DIR Management of the child with fever (Best Practice 5(5))
• DIR Medical identification and reporting of incest: recognising intrafamilial child sexual abuse
• DIR Migalastate — Adultos e adolescentes de 12 anos ou mais com diagnóstico de doença de Fabry e que possuam uma variante patogênica suscetível
• DIR Non-pharmacological management of fever in otherwise healthy children (Best Practice 16(7))
• DIR Onasemnogeno abeparvoveque — Tratamento de pacientes pediátricos até 6 meses de idade com Atrofia Muscular Espinhal (AME) do tipo I que estejam fora de ventilação invasiva acima de 16 horas por dia.
• DIR Parental involvement in their children’s postoperative pain management in hospital (Best Practice 16 (3))
• DIR Policies to protect children from the harmful impact of food marketing
• DIR Positioning of preterm infants for optimal physiological development (Best Practice 14(18))
• DIR Praziquantel — Crianças de 2 a 4 anos de idade com esquistossomose
• DIR PROPOSAL FOR A PROGRAMME FOR THE EARLY DETECTION OF INFANT DEAFNESS IN THE BASQUE AUTONOMOUS COMMUNITY
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Hemangioma Infantil
• DIR Raltegravir — Uso pediátrico
• DIR Ravulizumabe — Pacientes adultos e pediátricos com síndrome hemolítico-urêmica atípica
• DIR RESULTS OF THE PERINATAL CARE OF VERY PREMATURE CHILDREN IN THE HEALTH SERVICE OF THE BASQUE COUNTRY
• DIR Saturated fatty acid and trans-fatty acid intake for adults and children
• DIR Selumetinibe — Pediátricos com neurofibromatose tipo 1 (NF1) e neurofibroma plexiforme inoperável sintomático
• DIR Sistema de frequência modulada pessoal – FM — Equipamento que possibilita a acessibilidade da criança e/ou jovem com deficiência auditiva na escola
• DIR Testosterona injetável — Uso da testosterona injetável em homens e em adolescentes do sexo masculino com hipogonadismo hipogonadotrófico orgânico
• DIR The adolescent health indicators recommended by the Global Action for Measurement of Adolescent health
• DIR The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings (Best Practice 14(8))
• DIR The effectiveness of interventions for infant colic
• DIR The effectiveness of interventions for infant colic (Best Practice 12(6))
• DIR The experience and role of a companion during normal labor and childbirth (Best Practice 18(4))
• DIR The impact of hospital visiting hour policies on paediatric and adult patients and their visitors (Best Practice 14(14))
• DIR The Use of Growth Hormone in Children and Adults
• DIR Tiamazol — Hipertireoidismo em crianças e adolescentes
• DIR Transition from children's to adults' services
• DIR Transition from children's to adults' services for young people using health or social care services
• DIR Triagem neonatal por espectrometria de massas em tandem (MS/MS) — Detecção da deficiência de acil-CoA desidrogenase de cadeia média (MCADD)
• DIR Weight management: lifestyle services for overweight or obese children and young people (PH47)
• DIR WHO Guideline for complementary feeding of infants and young children 6-23 months of age
• DIR WHO guideline on mass drug administration of azithromycin to children under five years of age to promote child survival
• DIR WHO guidelines on parenting interventions to prevent maltreatment and enhance parent–child relationships with children aged 0–17 years
• DIR WHO recommendations for care of the preterm or low-birth-weight infant
• DIR Witholding & Withdrawing of Life Support in Children
• DIR Working with Families to Promote Safe Sleep for Infants 0-12 Months of Age

Documentos para Download:

• DIR 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the Respiratory Society (ERS)
• DIR Adult Asthma Care: Promoting Control of Asthma
• DIR Alteplase para tratamento da embolia pulmonar aguda — Embolia pulmonar aguda
• DIR ANALYSIS OF THE STATUS, SYSTEMATIC REVIEW AND VALIDATION OF A DIAGNOSTIC ALGORITHM FOR PULMONARY THROMBOEMBOLISM (PTE) IN THE HOSPITAL EMERGENCY SERVICES OF THE BASQUE HEALTH SERVICE
• DIR Asian Consensus on Diagnostic Pathways for Invasive Pulmonary Fungal Diseases in High-burden Countries
• DIR Asma
• DIR Asthma
• DIR Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)
• DIR Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)
• DIR ​Asthma in adults
• DIR ​Asthma in children
• DIR Asthma optimising long-term management with inhaled corticosteroid
• DIR Asthma pathway (BTS, NICE, SIGN)
• DIR Asthma pathway (BTS, NICE, SIGN) (NG244)
• DIR Australasian Bronchiolitis Guideline: 2023 Update
• DIR Australian Living Guidelines for the Management of Respiratory Distress Syndrome (RDS)
• DIR Beclometasona — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Benralizumabe — Adjuvante de manutenção para asma grave com fenótipo eosinofílico em pacientes adultos
• DIR Benralizumabe — Asma eosinofílica grave refratária em pacientes com idade de 18 anos ou mais
• DIR British guideline on the management of asthma (SIGN CPG 158)
• DIR Brometo de tiotrópio — Doença pulmonar obstrutiva crônica
• DIR Brometo de tiotrópio monoidratado + cloridrato de olodaterol — Doença pulmonar obstrutiva crônica graves e muito graves (estágio 3 e 4), com alto risco (C e D) e demais critérios definidos no Protocolo Clínico e Diretrizes Terapêuticas do Ministério da Sa
• DIR Brometo de umeclidínio + trifenatato de vilanterol — Doença pulmonar obstrutiva crônica.
• DIR Bronchiolitis in children
• DIR Bronchiolitis in children: diagnosis and management
• DIR Budesonida — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Budesonida 200mcg/formoterol 6mcg em suspensão aerossol — Asma
• DIR Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
• DIR Chronic Obstructive Pulmonary Disease (COPD) Guideline
• DIR Chronic obstructive pulmonary disease diagnosis and management
• DIR ​Chronic obstructive pulmonary disease in adults
• DIR Chronic obstructive pulmonary disease in adults
• DIR Chronic obstructive pulmonary disease in over 16s: diagnosis and management
• DIR Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
• DIR Clinical Practice Guideline on childhood asthma
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Pulmonary Evaluation and Optimization
• DIR Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease
• DIR Costs-impact analysis of a telemedicine procedure in spirometry quality assurance programs in patients with COPD
• DIR DESCRIPTION OF THE ELABORATION OF A CLINICAL PRACTICE GUIDELINE FOR ASTHMA IN THE AUTONOMOUS COMMUNITY OF THE BASQUE COUNTRY BY MEANS OF A MIXED METHOD OF ADAPTATION-DEVELOPMENT-ACTUALIZATION
• DIR Diagnosis and Management of Asthma in Adults
• DIR Diagnosis and Management of Asthma in Children
• DIR Dipropionato de beclometasona 100 µg fumarato de formoterol di-hidratado 6 µg e brometo de glicopirrônio 12,5 µg no tratamento da DPOC grave (30% ≤ VEF1 < 50%) e muito grave (VEF1 < 30%) grupo C e grupo D — Pulmonar obstrutiva crônica grave e muito grave
• DIR Doença Pulmonar Obstrutiva Crônica
• DIR Esilato de nintedanibe — Fibrose pulmonar idiopática
• DIR Evaluation of bubble humidification systems in low-flow oxygen therapy. Systematic review and cost analysis
• DIR Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
• DIR Everolimo — Transplantes pulmonares
• DIR Exames diagnósticos — Deficiência de alfa-1 antitripsina para portadores de DPOC
• DIR Fenoterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Fluticasona — Asma
• DIR Fluticasona — Doença pulmonar obstrutiva crônica
• DIR Fluticasona — Redução dos sintomas e exacerbações da asma em pacientes tratados com broncodilatadores isolados ou outra terapia profilática
• DIR Formoterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Furoato de fluticasona/brometo de umeclidínio/trifenatato — Doença Pulmonar Obstrutiva Crônica (DPOC) grave a muito grave (GOLD 3 e 4) com perfil exacerbador e sintomático (Grupo D)
• DIR Idiopathic pulmonary fibrosis in adults
• DIR Idiopathic pulmonary fibrosis in adults: diagnosis and management
• DIR Implante de válvulas endobronquiais unidirecionais — Enfisema pulmonar heterogêneo
• DIR Indacaterol — Doença pulmonar obstrutiva crônica
• DIR KNGF Guideline for Physical Therapy in patients with Chronic Obstructive Pulmonary Disease (COPD)
• DIR Management of Asthma in Adults
• DIR Management of Chronic Obstructive Pulmonary Disease (Second Edition)
• DIR Management of Pulmonary Aterial Hypertension (PAH)
• DIR Measurement of the fraction of exhaled nitric oxide in the diagnosis and treatment of asthmatic children
• DIR Mepolizumabe — Asma eosinofílica grave refratária em pacientes com idade de 18 anos ou mais
• DIR Mepolizumabe — Asma eosinofílica grave refratária entre 6 e 17 anos de idade
• DIR Nirsevimabe — Prevenção de infecção do trato respiratório inferior associado ao vírus sincicial respiratório para os bebês prematuros menores que 37 semanas e crianças menores de 2 anos portadores de comorbidades.
• DIR Nirsevimabe para Prevenção de Infecção do Trato Respiratório Inferior Associado ao Vírus Sincicial Respiratório para Bebês Prematuros ou com Comorbidades (Protocolo de Uso)
• DIR Nursing Care of Dyspnea:The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease
• DIR Omalizumabe — Asma grave
• DIR Oxigenação Extracorpórea (ECMO) — Suporte de Pacientes com Insuficiência Respiratória Grave e Refratária
• DIR Oxigenação por membrana extracorpórea — Suporte de pacientes com insuficiência respiratória grave
• DIR Oxigenoterapia domiciliar — Portadores de DPOC
• DIR Pirfenidona — Fibrose pulmonar idiopática
• DIR Promoting Asthma Control in Children
• DIR Propionato de fluticasona + xinafoato de salmeterol — Asma em pacientes a partir de 4 anos
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença Pulmonar Obstrutiva
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença Pulmonar Obstrutiva Crônica
• DIR Protocolo de Uso — Nirsevimabe para Prevenção de Infecção do Trato Respiratório Inferior Associado ao Vírus Sincicial Respiratório para Bebês Prematuros ou com Comorbidades
• DIR Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Adaptation from the American Thoracic Society Clinical Practice Guideline.
• DIR Roflumilaste — Doença obstrutiva crônica (DPOC)
• DIR Salbutamol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Salmeterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Sirolimo — Transplantes pulmonares
• DIR Specialist neonatal respiratory care for babies born preterm
• DIR Specialist neonatal respiratory care for babies born preterm
• DIR Spray de Formoterol + Budesonida — Asma
• DIR Support for Older People with COPD in Community Settings (Best Practice 17(4))
• DIR Tacrolimo — Transplantes pulmonares
• DIR The application of GRADE in the development of a CPG on childhood asthma
• DIR The use of inhalation chambers in the treatment of infantile asthma
• DIR Tiotrópio — Asma Moderada e grave em pacientes adultos e crianças (com idade de 6 anos ou mais)
• DIR Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
• DIR Vacina vírus sincicial respiratório (VSR) A e B (recombinante) — Prevenção da doença do trato respiratório inferior causada pelo vírus sincicial respiratório (VSR) em crianças até os 6 meses de idade
• DIR Xinafoato de Salmeterol aerossol bucal 50 mcg — Asma e da Doença Pulmonar Obstrutiva Crônica

Documentos para Download:

• PDF Eletroconvulsoterapia
• PDF Abuso e Dependência da Cocaína
• DIR AAOS Appropriate Use Criteria for the Early Screening for Psychosocial Risk and Protective Factors
• DIR ALTERNATIVES TO SHORT STAY PSYCHIATRIC HOSPITALISATION. INTENSIVE AMBULATORY MONITORING PROGRAMMES
• DIR A National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorders in Australia
• DIR AN EVALUATION OF THE EFFICACY OF PSYCHOSOCIAL TECHNIQUES (COGNITIVE REHABILITATION vs. PSYCHOEDUCATION) AS AN ADDITIONAL TREATMENT TO PHARMACOLOGICAL TREATMENT IN BIPOLAR DISORDER
• DIR Anxiety disorders
• DIR APPROACH TO PERSONALITY DISORDERS IN THE MENTAL HEALTH SYSTEM OF THE BASQUE COUNTRY
• DIR Assessment, diagnosis, care and support for people with dementia and their carers (SIGN CPG 168)
• DIR Assessment, diagnosis and interventions for autism spectrum disorders (SIGN CPG 145)
• DIR Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour
• DIR Assessment and clinical management of self-harm: evidence-based protocol
• DIR Assessment and Interventions for Perinatal Depression, Second Edition
• DIR Assisting caregivers to support people with dementia (Best Practice 14(9))
• DIR Australian Guidelines for the Prevention and Treatment of Acute Stress Disorder, Posttraumatic Stress Disorder and Complex Posttraumatic Stress Disorder
• DIR Australian guidelines on the treatment of acute stress disorder and posttraumatic stress disorder
• DIR Autism
• DIR Autism spectrum disorder in adults: diagnosis and management
• DIR Autism spectrum disorder in under 19s: recognition, referral and diagnosis
• DIR Autism spectrum disorder in under 19s: support and management
• DIR Bipolar disorder, psychosis and schizophrenia in children and young people
• DIR Bipolar disorder: assessment and management
• DIR Bipolar disorder in adults
• DIR Caregiving experiences of families living with persons with schizophrenia (Best Practice 18(6))
• DIR CASE AND CONTROL STUDY: EFFICIENCY OF THE PSYCHOEDUCATIONAL TREATMENT OF THE OVERLOAD EXPERIENCED BY FAMILY MEMBERS OF BIPOLAR PATIENTS
• DIR Clinical Practice Guideline for the Appropriate Use of Methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder
• DIR Clinical Practice Guideline for the Appropriate Use of Psilocybin-assisted Psychotherapy for Depression
• DIR Clinical practice guideline for the prevention and treatment of suicidal behaviour
• DIR Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
• DIR Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults
• DIR Clinical practice guideline on the management of depression in adults.
• DIR Clozapina — Transtorno Afetivo Bipolar
• DIR Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings
• DIR Coexisting severe mental illness and substance misuse
• DIR Coexisting severe mental illness and substance misuse: community health and social care services
• DIR Common mental health problems: identification and pathways to care (CG123)
• DIR Complex interactive factors which determine carers' experiences of seeking help for relatives with first- episode psychosis (Best Practice 18(10))
• DIR Comportamento Agressivo no Transtorno do Espectro do Autismo
• DIR Delirium, Dementia, and Depression in Older Adults: Assessment and Care
• DIR Dementia
• DIR Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset
• DIR Dementia: assessment, management and support for people living with dementia and their carers
• DIR Dementia: which non-pharmacological interventions ?
• DIR Depression in adolescents and young adults
• DIR Depression in adults
• DIR Depression in adults: treatment and management
• DIR Depression in adults with a chronic physical health problem: recognition and management
• DIR Depression in children and young people
• DIR Depression in children and young people: identification and management
• DIR Diagnosis and Management of Autism Spectrum Disorder
• DIR Diagnosis and Management of Generalized Anxiety Disorder in Adults
• DIR Drug misuse in over 16s: opioid detoxification
• DIR Drug misuse in over 16s: psychosocial interventions
• DIR Eating disorders
• DIR Eating disorders (SIGN CPG 146)
• DIR Eating disorders: recognition and treatment
• DIR Educational interventions for mental health consumers receiving psychotropic medication (Best Practice 10(4))
• DIR Effectiveness of music listening in reducing depressive symptoms in adults (Best Practice 15(12))
• DIR EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
• DIR EFNS task force: the use of neuroimaging in the diagnosis of dementia
• DIR Engaging Clients Who Use Substances
• DIR Environmental healthcare design strategies and event related anxiety in pediatric patients (Best Practice 16(11))
• DIR Esquizofrenia
• DIR Evaluation of care quality in the NHS towards severe childhood mental disorders. A study in infant/juvenile mental health services
• DIR Family involvement in decision making for people with dementia in residential aged care (Best Practice 18(2))
• DIR Generalised anxiety disorder – easing burden and enabling remission
• DIR Generalised anxiety disorder and panic disorder in adults: management
• DIR Geographical mental health map: geographical variation in psychosis and association with environmental factors
• DIR Group and individual therapy in the treatment of depression (Best Practice 3(2))
• DIR GROUP MONITORING OF PSYCHOTIC PATIENTS IN THE PUBLIC HEALTH NETWORK OF THE BASQUE AUTONOMOUS COMMUNITY
• DIR Guía de Práctica Clínica de Intervenciones Psicosociales en el Trastorno Mental Grave. Revisión
• DIR Guía de práctica clínica sobre las intervenciones terapéuticas en el Trastorno por Déficit de Atención con Hiperactividad (TDAH)
• DIR Guidelines on mental health promotive and preventive interventions for adolescents
• DIR Interventions to reduce undernutrition and promote eating in older adults with dementia (Best Practice 15(14))
• DIR Lamotrigina — Transtorno Afetivo Bipolar
• DIR Learning disability: identifying and managing mental health problems
• DIR Major depressive disorder – achieving and sustaining remission
• DIR Management of Anxiety and Depression in Adult Survivors of Cancer
• DIR Management of autism in children and young people: a good clinical practice guideline
• DIR Management of Autism Spectrum Disorder in Children and Adolescents
• DIR Management of Bipolar Disorder in Adults
• DIR Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
• DIR Management of Dementia (2nd edition)
• DIR Management of Major Depressive Disorder (Second Edition)
• DIR Management of schizophrenia (SIGN CPG 131)
• DIR Management of Schizophrenia in Adults
• DIR Mental health care in the perinatal period: Australian clinical practice guideline
• DIR Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
• DIR Mental health of adults in contact with the criminal justice system
• DIR Mental health of adults in contact with the criminal justice system
• DIR Mental health problems in people with learning disabilities: prevention, assessment and management
• DIR METRC/AAOS Clinical Practice Guideline for Limb Salvage or Early Amputation
• DIR MODELS OF COLLABORATION AND INTERVENTION BETWEEN PRIMARY CARE AND MENTAL HEALTH IN THE CARE OF PATIENTS DIAGNOSED WITH DEPRESSION: RESULTS OF A META-REVIEW
• DIR Music interventions for dental anxiety in paediatric and adult patients (Best Practice 15(2))
• DIR Olanzapina — Transtorno Afetivo Bipolar
• DIR Opioides fortes (fentanila, oxicodona e buprenorfina) — Dor crônica
• DIR Oral hygiene care for adults with dementia in residential aged care facilities (Best Practice 8(4))
• DIR Palliative approach to care for people with advanced dementia (Best Practice 15(5))
• DIR Palliative care for adults: strong opioids for pain relief
• DIR Palmitato de paliperidona — Esquizofrenia
• DIR Perinatal mental health conditions (SIGN CPG 169)
• DIR Preventing suicide in community and custodial settings
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Comportamento Agressivo no Transtorno do Espectro do Autismo
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Transtorno do Déficit de Atenção com Hiperatividade (TDAH)
• DIR Psychosis and schizophrenia in adults
• DIR Psychosis and schizophrenia in adults: prevention and management
• DIR Psychosis and schizophrenia in children and young people: recognition and management
• DIR Quetiapina — Transtorno Afetivo Bipolar
• DIR Recommandation sur l’utilisation d’un instrument de dépistage de la dépression chez les adultes
• DIR Recommendations on screening for depression in adults
• DIR RELATIONSHIP BETWEEN USE OF CANNABIS AND OTHER DRUGS AND PSYCHIATRIC PATHOLOGY IN ADOLESCENTS. A PROPOSAL OF INPATIENT AND OUTPATIENT MENTAL HEALTH CARE IN THE BASQUE HEALTH SERVICE
• DIR Risperidona — Dependência de cocaína/crack
• DIR Risperidona — Transtorno Afetivo Bipolar
• DIR Risperidona — Transtorno do Espectro do Autismo (TEA)
• DIR Risperidona no comportamento agressivo — Adultos com transtornos do espectro do autismo (TEA)
• DIR Screening for psychosocial distress
• DIR Self-harm: assessment, management and preventing recurrence
• DIR Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services
• DIR Service user experience in adult mental health services
• DIR Social anxiety disorder: recognition, assessment and treatment
• DIR STUDY OF RISK FACTORS IN SUICIDAL CONDUCT. HEALTH CARE ANALYSIS
• DIR Sucide and Non-Suicidal Self-injury in Chidlren and Adolescents; an evidence based clinical practice guideline
• DIR Suicide prevention
• DIR The best evidence for assisted bathing of older people with dementia (Best Practice 17(3))
• DIR The Effectiveness of Individual Therapy and Group Therapy in the Treatment of Schizophrenia (Best Practice 3(4))
• DIR The long-term efficacy of psychotherapy, alone or in combination with antidepressants, in the treatment of adult major depression
• DIR The National Dementia Guidelines
• DIR The perception and experience of stigma among people with schizophrenia (Best Practice 16(4))
• DIR THERAPEUTIC STRATEGIES IN REFRACTORY SCHIZOPHRENIA OR TREATMENT RESISTANT SCHIZOPHRENIA
• DIR Transition between inpatient mental health settings and community or care home settings
• DIR Transition between inpatient mental health settings and community or care home settings
• DIR Transtorno Afetivo Bipolar do Tipo I
• DIR Transtorno do Déficit de Atenção com Hiperatividade - TDAH
• DIR Unipolar depression – German National Disease Management Guideline
• DIR Update of the Australian Guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder
• DIR Violent and aggressive behaviours in people with mental health problems
• DIR WHO guidelines on mental health at work

Documentos para Download:

• PDF Recomendações de esclerose sistêmica
• PDF Capilaroscopia Prognostico Na Esclerose Sistêmica (ES)
• PDF Miopatias autoimunes sistêmicas ressonância magnética
• PDF Miopatias autoimunes sistêmicas (mas): biópsia muscular
• PDF Miopatias autoimunes sistêmicas critérios classificatórios
• PDF Miopatias autoimunes sistêmicas tratamento não medicamentoso
• PDF Miopatias autoimunes sistêmicas diagnóstico clínico/laboratorial de resposta terapêutica
• PDF Miopatias autoimunes sistêmicas diagnóstico de comorbidades
• PDF Miopatias autoimunes sistêmicas diagnóstico diferencial
• PDF Miopatias autoimunes sistêmicas eletroneuromiografia
• PDF Miopatias autoimunes sistêmicas (mas): monitoramento e seguimento
• PDF Miopatias autoimunes sistêmicas papel diagnóstico dos anticorpos miosite-específicos ou miosite-relacionados
• PDF Miopatias autoimunes sistêmicas risco de neoplasias
• PDF Miopatias autoimunes sistêmicas recomendações gerais e educação
• PDF Miopatias autoimunes sistêmicas cuidados antes do início da imunossupressão
• PDF Capilaroscopia - Equipamentos para a realização do exame
• PDF Capilaroscopia - Parametros Periungueal – alterações morfológicas no padrão SD
• PDF Capilaroscopia - Periungueal padrão SD na esclerose sistêmica
• PDF Osteoporose Masculina - diagnostico e tratamento
• PDF Osteoporose em mulheres na pós menopausa - diagnostico e tratamento
• PDF Capilaroscopia - Seguimento Na Esclerose Sistêmica
• PDF Capilaroscopia - Indicações Na Reumatologia
• PDF Capilaroscopia Periungueal - Padrão Capilaroscópico Normal
• PDF Capilaroscopia - Prognóstico Na Esclerose Sistêmica (Es)
• PDF Capilaroscopia – Risco de desenvolvimento de úlceras digitais esclerose sistêmica
• DIR 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition)
• DIR Abatacepte — Artrite reumatoide
• DIR Abatacepte — Artrite Reumatoide Moderada a Grave após falha aos MMCDs sintéticos
• DIR Abatacepte — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Abatacepte subcutâneo — Artrite reumatoide moderada a grave
• DIR Abatacepte subcutâneo — Tratamento da segunda etapa (primeira etapa de biológicos) do tratamento da artrite reumatoide moderada a grave
• DIR Adalimumabe — Artrite reumatoide
• DIR Adalimumabe — Doença reumatoide do pulmão e vasculite reumatoide
• DIR Artrite Idiopática Juvenil
• DIR Artrite Reativa
• DIR Artrite Reumatóide
• DIR Azatioprina — Artrite reumatoide
• DIR Azatioprina — Vasculite associada aos anticorpos anti-citoplasma de neutrófilos - ANCA
• DIR Baricitinibe — Artrite Reumatoide ativa, moderada a grave
• DIR Belimumabe — Lúpus eritematoso sistêmico
• DIR Belimumabe intravenoso — Tratamento adjuvante de pacientes adultos com lúpus eritematoso sistêmico com alto grau de atividade apesar da terapia padrão e que apresentem falha terapêutica a dois imunossupressores prévios
• DIR Canaquinumabe — Artrite Idiopática Juvenil Sistêmica
• DIR Certolizumabe pegol — Artrite reumatoide
• DIR Certolizumabe pegol — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Certolizumabe Pegol — Espondiloartrite Axial
• DIR Ciclofosfamida — Vasculite associada aos ANCA
• DIR Ciclofosfamida — Vasculite associada aos anticorpos anti-citoplasma de neutrófilos do tipo granulomatose com poliangiite ou poliangiite microscópica submetidos à terapia de indução de remissão
• DIR Ciclosporina — Síndrome de Felty (CID M050), Artrite reumatoide com comprometimento de outros órgãos e sistemas (M053), outras artrites reumatoides soropositivas (M058), Artrite reumatoide soronegativa (M060) e outras artrites reumatoides especificadas (M
• DIR Clinical Practice Guideline on the Management of Patients with Rheumatoid Arthritis
• DIR Clinical Practice Guideline on the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis
• DIR Cloroquina — Doença Reumatoide do Pulmão (CID M051) e Vasculite Reumatoide (CID M052)
• DIR Definition, pathophysiology, diagnostics and therapy of fibromyalgia
• DIR Diagnosis of Acute Gout: A Clinical Practice Guideline From the American College of Physicians
• DIR Etanercepte — Artrite reumatoide
• DIR Etanercepte — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Golimumabe — Artrite reumatoide
• DIR Golimumabe — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Gout: diagnosis and management
• DIR Gout achieving the management goal
• DIR Hidroxicloroquina — Doença Reumatoide do Pulmão (CID M051) e Vasculite Reumatoide (CID M052)
• DIR Infliximabe — Artrite reumatoide
• DIR Infliximabe — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR International Consensus Guidance for the use of Tripterygium wilfordii Hook F in the treatment of active rheumatoid arthritis
• DIR Ixequizumabe — Adultos com espondiloartrite axial radiográfica e não radiográfica que não responderam à terapia convencional (antiinflamatórios não esteroides)
• DIR Leflunomida — Doença Reumatoide do Pulmão (CID M051) e Vasculite Reumatoide (CID M052)
• DIR Lúpus Eritematoso Sistêmico
• DIR Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians
• DIR Management of early rheumatoid arthritis (SIGN CPG 123)
• DIR Management of Gout
• DIR Management of Rheumatoid Arthritis
• DIR Metotrexato — Doença Reumatoide do Pulmão (CID M051) e Vasculite Reumatoide (CID M052)
• DIR Metotrexato — Vasculite associada aos anticorpos anti-citoplasma de neutrófilos - ANCA
• DIR Micofenolato de mofetila — Vasculite associada aos ANCA
• DIR Naproxeno — Artrite reativa
• DIR Naproxeno — Artrite reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Idiopática Juvenil
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Idiopática Juvenil
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Idiopática Juvenil (AIJ)
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reativa
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Artrite Reumatoide
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Lúpus Eritematoso Sistêmico
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Vasculite Associada aos Anticorpos Anti-citoplasma de Neutrófilos
• DIR Rheumatoid arthritis in adults: management
• DIR Rheumatoid arthritis in over 16s
• DIR Rituximabe — Artrite reumatoide
• DIR Rituximabe — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Rituximabe — Terapia de indução de remissão dos pacientes com diagnóstico recente em idade fértil e para os casos de recidiva de vasculites associadas aos anticorpos anti-citoplasma de neutrófilos (VAA), classificados como granulomatose com poliangeite (G
• DIR Rituximabe — Vasculite associada aos anticorpos anti-citoplasma de neutrófilos - ANCA
• DIR Secuquinumabe como primeira etapa de terapia biológica — Espondiloartrite axial em pacientes adultos
• DIR Spondyloarthritis
• DIR Spondyloarthritis in over 16s: diagnosis and management
• DIR Sulfassalazina — Doença Reumatoide do Pulmão (CID M051) e Vasculite Reumatoide (CID M052)
• DIR Teste de detecção de HLA-B27 — Indivíduos com suspeita de espondiloartrite axial
• DIR Testes de Elisa — Mieloperoxidase (MPO)-ANCA e para proteinase (PR3)-ANCA para diagnóstico de pacientes com suspeita de Vasculite Associada aos Anticorpos Anticitoplasma de Neutrófilos (ANCA)
• DIR The recognition, diagnosis and management of cerebral vasculitis: a European survey
• DIR Tocilizumabe — Artrite reumatoide
• DIR Tocilizumabe — Artrite reumatoide - 1ª linha de tratamento com biológicos após falha a MMCDs sintéticos
• DIR Tocilizumabe — Doença Reumatoide do Pulmão e Vasculite Reumatoide
• DIR Tocilizumabe em monoterapia — Segunda etapa de tratamento da artrite reumatoide moderada a grave
• DIR Tofacitinibe — Adultos com artrite reumatoide ativa moderada a grave com resposta inadequada a um ou mais medicamentos modificadores do curso da doença
• DIR Upadacitinibe — Adultos com artrite reumatoide ativa moderada a grave
• DIR Vasculite
• DIR WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease

Documentos para Download:

• PDF Cistite intersticial - tratamento oral
• PDF Disfunções neurológicas do trato urinário inferior
• PDF Litíase urinária – investigação diagnóstica
• PDF Disfunção erétil tratamento medicamentoso
• PDF Infecções sexualmente transmissíveis (ist) : diagnóstico laboratorial
• PDF Litíase urinária - avaliação do uso da litotripsia ureteral a laser versus pneumática
• PDF Litíase urinária - cirurgia convencional aberta
• PDF Bexiga hiperativa tratamento farmacológico
• PDF Cistite intersticial - Diagnóstico
• PDF Adrenalectomia laparoscópica total e parcial
• PDF Hiperplasia prostática benigna – tratamento minimamente invasivo
• PDF Esfíncter artificial na incontinência urinária masculina - Abordagem escrotal versus perineal
• PDF Esfíncter artificial na incontinência urinária masculina - Cuidados peri e pós-operatório
• PDF Hiperplasia Prostática Benigna - Terapia Minimamente Invasiva
• PDF Hiperplasia Prostática Benigna - Tratamento
• PDF Hiperplasia Prostática Benigna - Prostatectomia por vaporização a laser
• PDF Biópsia Renal Laparoscópica
• PDF Nefrectomia do Doador Vivo
• PDF Adenocarcinoma Metastático De Próstata Resistente À Castração
• PDF Esfíncter Artificial Na Incontinência Urinária Masculina
• PDF Esfíncter Artificial Na Incontinência Urinária Masculina Modelo Ams 800
• PDF Esfíncter Artificial Na Incontinência Urinária Masculina Pré-Operatório
• PDF Esfíncter Urinário Artificial - Abordagem Transcorporal Para O Cuff
• DIR Acetato de ciproterona — Pacientes com adenocarcinoma de próstata resistente à castração
• DIR Adenocarcinoma de Próstata
• DIR ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence
• DIR Bladdercarcinoma
• DIR Cateter hidrofílico — Cateterismo vesical intermitente em indivíduos com lesão medular e bexiga neurogênica
• DIR Darifenacina — Disfunção de armazenamento em pacientes com bexiga neurogênica
• DIR Darifenacina — Incontinência urinária de urgência (IUU)
• DIR Diretrizes Diagnósticas e Terapêuticas — Adenocarcinoma de Próstata
• DIR Effectiveness of a pelvic floor muscle exercise program on urinary incontinence following childbirth (Best Practice 9(2))
• DIR Esfíncter urinário artificial — Incontinência urinária masculina grave pós-prostatectomia
• DIR European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Gui
• DIR Faecal incontinence in adults
• DIR Faecal incontinence in adults: management
• DIR Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management 17-3V2
• DIR Identificação de glicídios urinários por cromatografia (camada delgada) — Doenças Raras
• DIR Identificação de glicosaminoglicanos urinários por cromatografia em camada delgada, eletroforese e dosagem quantitativa — Doenças Raras
• DIR Implante de esfíncter urinário artificial — Incontinência urinária grave pós-prostatectomia radical
• DIR Incontinência Urinária não Neurogênica
• DIR KNGF Evidence Statement Anal Incontinence
• DIR Lower urinary tract symptoms in men
• DIR Lower urinary tract symptoms in men: management
• DIR Mirabegrona — Disfunção de armazenamento em pacientes com bexiga neurogênica
• DIR Mirabegrona — Incontinência urinária de urgência (IUU)
• DIR Nonsurgical Management of Urinary Incontinence in Women: A Clinical Practice Guideline From the American College of Physicians
• DIR Oxibutinina — Disfunção de armazenamento em pacientes com bexiga neurogênica
• DIR Oxibutinina — Incontinência urinária de urgência (IUU)
• DIR Prostatectomia radical assistida por robô — Câncer de próstata localizado
• DIR Prostatectomia radical assistida por robô — Pacientes com câncer de próstata clinicamente localizado ou localmente avançado
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Incontinência Urinária não Neurogênica
• DIR Recommandations sur le dépistage du cancer de la prostate par le dosage de l’antigène prostatique spécifique
• DIR Sistema cirúrgico robótico — Cirurgia minimamente invasiva: Prostatectomia radical
• DIR Solifenacina — Disfunção de armazenamento em pacientes com bexiga neurogênica
• DIR Solifenacina — Incontinência urinária de urgência (IUU)
• DIR Strategies to promote intermittent self-catheterization in adults with neurogenic bladders (Best Practice 15(7))
• DIR Tolterodina — Disfunção de armazenamento em pacientes com bexiga neurogênica
• DIR Tolterodina — Incontinência urinária de urgência (IUU)
• DIR Toxina Botullínica — Bexiga hiperativa
• DIR Ureterolitotripsia transureteroscópica — Litíase do trato urinário
• DIR Urinary incontinence and pelvic organ prolapse in women: management
• DIR Urinary incontinence in neurological disease: assessment and management
• DIR Urinary incontinence in women